Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ZNTL will decline by -8.40% over the next 2 Weeks and hit $4.22 by Monday, July 13, 2026. In that time frame, ZNTL's share price is expected to range between $3.99 and $4.45.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 13, 2026 | 3.99 | 4.22 | 4.45 |
| Jul 10, 2026 | 4.02 | 4.25 | 4.47 |
| Jul 9, 2026 | 4.08 | 4.30 | 4.54 |
| Jul 8, 2026 | 4.04 | 4.26 | 4.50 |
| Jul 7, 2026 | 3.94 | 4.17 | 4.41 |
| Jul 6, 2026 | 4.04 | 4.27 | 4.51 |
| Jul 3, 2026 | 4.07 | 4.30 | 4.53 |
| Jul 2, 2026 | 4.11 | 4.35 | 4.58 |
| Jul 1, 2026 | 4.06 | 4.31 | 4.53 |
| Jun 30, 2026 | 3.98 | 4.21 | 4.45 |
ZNTL shares rose +5.21% in Tuesday, June 30, 2026's trading session, rising from a previous close of $4.61 to move at $4.85. The stock demonstrated notable intraday movement (see ZNTL's key stats for a full breakdown), fluctuating between $4.49 and $5.11, a +13.94% trading range. While recent weeks have seen some volatility, ZNTL has managed to secure a +37.78% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.85M shares changing hands, 905.72K fewer than the previous session. This amounted to $8.98M in total market activity.
Will ZNTL Continue Its Downward Trend?
According to analyst ratings and projections for ZNTL, Zentalis Pharmaceuticals, Inc. shares are anticipated to decrease by -8.99%, potentially reaching $4.45 per share by July 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for ZNTL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the ZNTL stock forecast, now is not the best time to buy ZNTL stock because its current trading price is +14.86% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ZNTL covering social and institutional perspectives.
ZNTL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ZNTL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 64.75% to 78.00%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 58.15%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 56.00%, maintains a neutral outlook for the long term. Insights into ZNTL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Zentalis Pharmaceuticals Short-Term Forecasts
ZNTL Forecast For Next 5 Days
Our algorithm anticipates Zentalis Pharmaceuticals (ZNTL) stock could hit $5.01 by Jul 07, 2026. This represents a +3.23% fall from today's price, following a -17.77% change over the past five days.
ZNTL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Zentalis Pharmaceuticals, Inc. (ZNTL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $5.48, which would mean a +12.99% increase from the current price of $4.85. Projections for this period range from a high of $7.20 to a low of $3.72.
ZNTL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Zentalis Pharmaceuticals's price over the next three months point to a rise. ZNTL stock is expected to peak at $10.56 on Sep 11, 2026 after potentially dipping to $3.79 on Jul 27, 2026. On average, ZNTL is likely to trade around $6.66 in the coming 90 days.
Zentalis Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Zentalis Pharmaceuticals (ZNTL) is expected to trade between $3.18 and $10.56 throughout 2026. This would result in an average price of $6.25, potentially offering investors a +28.87% return from current levels.
Zentalis Pharmaceuticals, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Zentalis Pharmaceuticals, Inc. (ZNTL) is positioned to show a strong performance in June 2026. The price is predicted to move between $6.72 and $7.21, settling at an average of $6.99. This could translate to a +44.12% gain.
July 2026
Based on current market signals, Zentalis Pharmaceuticals, Inc. is projected to trend july 2026. We forecast a trading range from $3.79 to $7.15, with a likely average price of $4.92. Investors could expect a potential return of +1.44%.
August 2026
Our predictive algorithms indicate Zentalis Pharmaceuticals, Inc. stock may see a shift in August 2026. The expected range spans $4.20–$9.85, with an average target of $6.15. This represents a positive outlook and a possible gain of +26.80%.
September 2026
Analyzing established trends, Zentalis Pharmaceuticals, Inc. looks set to move in September 2026. Projections place the stock between $6.45 and $10.56, averaging around $8.96. This suggests a +84.74% gain from current levels.
October 2026
Market indicators suggest Zentalis Pharmaceuticals, Inc. could experience notable changes during October 2026. Prices could fluctuate within $4.19 to $7.92, with a midpoint forecast of $6.68. The stock might deliver a +37.73% gain.
November 2026
Forecasting for November 2026, models estimate that Zentalis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.55 and $7.60, averaging $5.58. This signals a positive trajectory with potential returns around +15.05%.
December 2026
According to our latest forecast models, Zentalis Pharmaceuticals, Inc. (ZNTL) is positioned to show a strong performance in December 2026. The price is predicted to move between $3.18 and $6.43, settling at an average of $5.25. This could translate to a +8.25% gain.
January 2027
Based on current market signals, Zentalis Pharmaceuticals, Inc. is projected to trend january 2027. We forecast a trading range from $3.61 to $11.12, with a likely average price of $7.76. Investors could expect a potential return of +60.00%.
February 2027
Our predictive algorithms indicate Zentalis Pharmaceuticals, Inc. stock may see a shift in February 2027. The expected range spans $4.58–$12.98, with an average target of $10.39. This represents a positive outlook and a possible gain of +114.23%.
March 2027
Analyzing established trends, Zentalis Pharmaceuticals, Inc. looks set to move in March 2027. Projections place the stock between $3.81 and $14.08, averaging around $10.72. This suggests a +121.03% gain from current levels.
April 2027
Market indicators suggest Zentalis Pharmaceuticals, Inc. could experience notable changes during April 2027. Prices could fluctuate within $3.84 to $17.88, with a midpoint forecast of $12.78. The stock might deliver a +163.51% gain.
May 2027
Forecasting for May 2027, models estimate that Zentalis Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.09 and $15.66, averaging $10.16. This signals a positive trajectory with potential returns around +109.48%.
June 2027
According to our latest forecast models, Zentalis Pharmaceuticals, Inc. (ZNTL) is positioned to show a strong performance in June 2027. The price is predicted to move between $3.59 and $24.24, settling at an average of $13.93. This could translate to a +187.22% gain.
ZNTL's history of dividends and stock splits also plays a role in long-term investor confidence.